Goodness Growth to Enter Psychedelic Research

Following success in cannabis research, Minnesota-based Goodness Growth Inc. has announced their plans to enter the psychedelics world. They intend to initiate clinical research into plant-based psychedelic medicine. This research will be conducted by their subsidiary, Resurgent Biosciences.

Resurgent Biosciences is a non-plant touching entity, which focuses on developing naturally-derived medicines, therapies, products, and technologies for use in health, wellness, and recreation. Psychedelics have been an increasingly popular topic of research, as their benefits are being uncovered in areas like mental health and anxiety treatment. Recent studies have been published highlighting the efficacy of psilocybin as a treatment for depression. 

“I wanted to wait for a kind of threshold of evidence to make sure this was a real opportunity, and that it would be real medicine for people ” said Dr. Kyle Kingsley, CEO of Goodness Growth. “It’s gone beyond that. It’s really sort of exceeded my expectations as far as the therapeutic potential of psychedelics.”

Following these research advancements, Goodness Growth decided to join the game and begin contributing to this clinical research. They intend to partner with other like-minded businesses to begin expanding this research body before moving into commercialization. They believe psychedelics will significantly alter the landscape for treatment of psychiatric disorders in the same way cannabis altered treatment of chronic pain. 

Are you developing new technology for a new application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts